138 related articles for article (PubMed ID: 9421084)
1. Progressing imbalance between proliferation and apoptosis with increasing severity of cervical intraepithelial neoplasia.
ter Harmsel B; Kuijpers J; Smedts F; Jeunink M; Trimbos B; Ramaekers F
Int J Gynecol Pathol; 1997 Jul; 16(3):205-11. PubMed ID: 9421084
[TBL] [Abstract][Full Text] [Related]
2. BCL-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma.
Ter Harmsel B; Smedts F; Kuijpers J; Jeunink M; Trimbos B; Ramaekers F
J Pathol; 1996 May; 179(1):26-30. PubMed ID: 8691340
[TBL] [Abstract][Full Text] [Related]
3. Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma.
Feng W; Xiao J; Zhang Z; Rosen DG; Brown RE; Liu J; Duan X
Mod Pathol; 2007 Sep; 20(9):961-6. PubMed ID: 17632454
[TBL] [Abstract][Full Text] [Related]
4. Changes in the topological expression of markers of differentiation and apoptosis in defined stages of human cervical dysplasia and carcinoma.
Zanotti S; Fisseler-Eckhoff A; Mannherz HG
Gynecol Oncol; 2003 Jun; 89(3):376-84. PubMed ID: 12798698
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53, bcl-2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Looi ML; Dali AZ; Ali SA; Ngah WZ; Yusof YA
Anal Quant Cytol Histol; 2008 Apr; 30(2):63-70. PubMed ID: 18561741
[TBL] [Abstract][Full Text] [Related]
6. The role of p53, Bcl-2 and Ki-67 in premalignant cervical lesions and cervical cancer.
Türkçüoğlu I; Tezcan S; Kaygusuz G; Atabekoğlu CS; Ortaç F; Güngör M; Kankaya D; Sertçelik A
Eur J Gynaecol Oncol; 2007; 28(4):290-3. PubMed ID: 17713095
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis, cell proliferation and apoptosis in progression of cervical neoplasia.
Lee JS; Kim HS; Jung JJ; Lee MC; Park CS
Anal Quant Cytol Histol; 2002 Apr; 24(2):103-13. PubMed ID: 12026048
[TBL] [Abstract][Full Text] [Related]
8. Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.
Reesink-Peters N; Hougardy BM; van den Heuvel FA; Ten Hoor KA; Hollema H; Boezen HM; de Vries EG; de Jong S; van der Zee AG
Gynecol Oncol; 2005 Mar; 96(3):705-13. PubMed ID: 15721415
[TBL] [Abstract][Full Text] [Related]
9. Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions.
Saha B; Chaiwun B; Tsao-Wei DD; Groshen SL; Naritoku WY; Atkinson RD; Taylor CR; Imam SA
Int J Gynecol Pathol; 2007 Jul; 26(3):214-22. PubMed ID: 17581401
[TBL] [Abstract][Full Text] [Related]
10. Positive association between STAT3 and Ki-67 in cervical intraepithelial neoplasia.
Yang SF; Yuan SS; Yeh YT; Hung SC; Wu MT; Su JH; Chai CY
Kaohsiung J Med Sci; 2006 Nov; 22(11):539-46. PubMed ID: 17110342
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical analysis of sex-steroid receptors, tumor suppressor gene p53 and Ki-67 in the normal and neoplastic uterine cervix squamous epithelium.
Nikolaou M; Koumoundourou D; Ravazoula P; Papadopoulou M; Michail G; Decavalas G
Med Pregl; 2014; 67(7-8):202-7. PubMed ID: 25151759
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody MIB1 in the assessment of cervical squamous intraepithelial lesions.
McCluggage WG; Buhidma M; Tang L; Maxwell P; Bharucha H
Int J Gynecol Pathol; 1996 Apr; 15(2):131-6. PubMed ID: 8786202
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of metallothionein and MIB1 in uterine cervical squamous lesions.
McCluggage WG; Maxwell P; Bharucha H
Int J Gynecol Pathol; 1998 Jan; 17(1):29-35. PubMed ID: 9475189
[TBL] [Abstract][Full Text] [Related]
14. Utility of Ki-67 and p53 in distinguishing cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix.
Tan GC; Sharifah NA; Shiran MS; Salwati S; Hatta AZ; Paul-Ng HO
Asian Pac J Cancer Prev; 2008; 9(4):781-4. PubMed ID: 19256776
[TBL] [Abstract][Full Text] [Related]
15. bcl-2 protein expression in cervical intraepithelial neoplasia: no evidence of a prognostic significance in mild and moderate lesions.
Ciavattini A; Lucarini G; Castaldini C; Goteri G; Romanini C; Biagini G; Garzetti GG
Anticancer Res; 1999; 19(6B):5463-7. PubMed ID: 10697578
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix proteins in uterine cervical neoplasia using immunohistochemistry.
Davidson B; Goldberg I; Gotlieb WH; Ben-Baruch G; Kopolovic J
Eur J Obstet Gynecol Reprod Biol; 1998 Jan; 76(1):109-14. PubMed ID: 9481557
[TBL] [Abstract][Full Text] [Related]
17. Apotosis-related proteins in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix.
Cheung TH; Chung TK; Lo KW; Yu MY; Krajewski S; Reed JC; Wong YF
Gynecol Oncol; 2002 Jul; 86(1):14-8. PubMed ID: 12079293
[TBL] [Abstract][Full Text] [Related]
18. The two faces of cervical adenocarcinoma in situ.
Smedts F; Ramaekers FC; Hopman AH
Int J Gynecol Pathol; 2010 Jul; 29(4):378-85. PubMed ID: 20567153
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the Bcl-2 and C-myc expression in relationship to the Ki-67 labelling index in cervical intraepithelial neoplasia.
Dellas A; Schultheiss E; Holzgreve W; Oberholzer M; Torhorst J; Gudat F
Int J Gynecol Pathol; 1997 Jul; 16(3):212-8. PubMed ID: 9421085
[TBL] [Abstract][Full Text] [Related]
20. Expression of bcl-2 and bax in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Aletra C; Ravazoula P; Scopa C; Kounelis S; Sotiropoulou G; Kourounis G; Ladopoulos I; Bonikos D
Eur J Gynaecol Oncol; 2000; 21(5):494-8. PubMed ID: 11198041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
